We are delighted by today's decision to allow patients with advanced prostate cancer to receive abiraterone on the NHS.
This drug was discovered at the Institute of Cancer Research and is the result of more than two decades of dedicated work by our scientists and and collaborators.
In clinical trials of men with advanced prostate cancer who have already tried chemotherapy, it has been shown to extend life by an average of four months and improve quality of life.
More top news
Nearly 38,000 runners will hope to complete Sunday's London Marathon making it the biggest event in its 35-year history.
Rain across central Britain with longer, intense downpours with thunder in places this evening. A lucky few will stay sunny and dry.
Planning on going to the London Marathon tomorrow? Read our handy guide first!